Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Currently, the first-generation drug pramlintide is used as an adjunct to insulin therapy in the treatment of T2D but is not approved for the treatment of obesity
Theres almost no human trials
Primary Cellular Pathways FAK/Paxillin Signaling Cell Migration and Adhesion BPC-157 significantly increases phosphorylation of focal adhesion kinase (FAK) and paxillin proteins in fibroblast cells, promoting enhanced cell adhesion and migration[1]
It is supplied in a sterile, lyophilized format for controlled laboratory research
It also serves as a cofactor for several enzymes involved in the biosynthesis of collagen, carnitine, and neurotransmitters, as well as in the metabolism of tyrosine and peptide hormones
For more on this, see our guide to Does Tesamorelin Suppress Appetite?, and how it is evaluated and treated at Perfect B in Doral
